A phase I pharmacokinetic study of NATESTO testosterone nasal gel in male patients with seasonal allergic rhinitis
Phase of Trial: Phase I
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- 04 Apr 2017 Results from this and NCT01446042 study investigating the impact of seasonal allergies on absorption of Natesto nasal gel in hypogonadal men, presented at The 99th Annual Meeting of the Endocrine Society.
- 07 Jul 2016 New trial record
- 17 Jun 2016 Results published in an Acerus Pharmaceuticals Corporation media release.